Morgan Dempsey Capital Management LLC Gilead Sciences, Inc. Transaction History
Morgan Dempsey Capital Management LLC
- $243 Million
- Q4 2024
A detailed history of Morgan Dempsey Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Morgan Dempsey Capital Management LLC holds 350 shares of GILD stock, worth $39,291. This represents 0.01% of its overall portfolio holdings.
Number of Shares
350
Previous 85,636
99.59%
Holding current value
$39,291
Previous $7.18 Million
99.55%
% of portfolio
0.01%
Previous 2.49%
Shares
24 transactions
Others Institutions Holding GILD
# of Institutions
2,100Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$13 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.05 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.78 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.51 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $141B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...